Bioxytran issues 28.97M preferred shares to insiders, converts 94M common shares and $354K debt

BIOXYTRAN, INC

Issued 28,971,248 convertible preferred shares to insiders in exchange for 94,057,658 common shares at a 5:1 ratio.
Preferred shares have super voting rights: vote on 'as if converted' basis multiplied by 2; insiders now control 77.9% voting power.
Conversion also extinguished $353,840 in accrued salaries, accounts receivable, and short-term debt plus 14.41M subsidiary shares.
Common shares outstanding reduced to 81,850,495; par value $0.001 per share; listed on OTCQB.
Press release announces peer-reviewed British Journal article on carbon monoxide in mitochondria, using MDX Viewer to validate BXT-25.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.